Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease

NCT00051909 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
200
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Eli Lilly and Company